Akebia Therapeutics (AKBA) Interest Coverage Ratio (2013 - 2026)

Akebia Therapeutics (AKBA) has 14 years of Interest Coverage Ratio data on file, last reported at 1.32 in Q1 2026.

• On a quarterly basis, Interest Coverage Ratio fell 120.56% year-over-year to 1.32 in Q1 2026; TTM through Mar 2026 was 1.49, a 133.39% increase from a year earlier, with the FY2025 full-year figure at 1.07, up 919.92% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 1.32, up from 5.09 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for AKBA reached as high as 30.77 in Q4 2024 and fell as low as 24.0 in Q3 2022.
• Historically, Interest Coverage Ratio has averaged 2.76 across 5 years, with a median of 5.09 in 2025.
• Across the five-year window, Interest Coverage Ratio slumped 144.55% in 2023 and jumped 2943.18% in 2024, its largest moves.
• Year by year, Interest Coverage Ratio stood at 6.54 in 2022, then slumped by 84.53% to 1.01 in 2023, then jumped by 2943.18% to 30.77 in 2024, then slumped by 116.55% to 5.09 in 2025, then jumped by 74.01% to 1.32 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 1.32 in Q1 2026, 5.09 in Q4 2025, and 0.29 in Q3 2025.